Trials / Completed
CompletedNCT03788421
Comparison Between 2 Techniques for Bilateral Salpingectomy
Comparison Between 2 Techniques for Bilateral Salpingectomy During Cesarean Section
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
A comparison between 2 techniques for bilateral salpingectomy during cesarean section. Primary outcomes are total operative time and bilateral completion of the randomized procedure. Secondary outcomes included surgical complications and post operation complications.
Detailed description
Ovarian cancer is the most lethal gynecologic malignancy. Major contributors to this high mortality are the lack of effective screening strategies, diagnosis at advanced stage of presentation as well as the high risk of recurrence. In the last years the Gynecologic Associations worldwide have recommended that total salpingectomy be considered for potential ovarian cancer risk reduction in benign gynecologic surgeries after completion of childbearing. However, the data are limit regarding the Preferred surgical technique during cesarean section. In this randomized controled trial the investigators will compare between various techniques for bilateral salpingectomy during cesarean section. Primary outcomes are total operative time and bilateral completion of the randomized procedure. Secondary outcomes included surgical complications and post operation complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LIGASURE | Electricity based cautery tool used during both laparoscopic and open surgery for optimal hemostasis. |
| PROCEDURE | Clamping and suturing | Step by step clamping and suturing of the mesosalpinx until achievement of total salpingectomy. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2021-01-01
- Completion
- 2021-09-01
- First posted
- 2018-12-27
- Last updated
- 2022-03-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03788421. Inclusion in this directory is not an endorsement.